semaglutide oral fda approval FDA-Approved Pills for Weight Loss Semaglutide Oral | Starts at
Description
Across both programs, researchers tracked adverse events meticulously, documenting everything from nausea to injection site reactions

Eur J Clin Invest (2003) 33(5):397401.10.1046/j.1365-2362.2003.01161.x 146 HortonFWrightJSmithLHintonPJRobertsonMD
In one of the key studies known as the STEP 5 trial, participants treated with GLP-1s experienced a mean weight reduction of 15.2% over a two-year period, compared to a 2.6% reduction in the placebo group

That P value of 0.2 means this increase was not statistically significant at the lowest dose
Shares in the latter fell sharply after the Hansoh deal was announced, alongside other smaller companies with weight-loss candidates, including Structure Therapeutics and Terns Pharma
Lower exposures can still produce meaningful changes